Minimizing Weapons-Usable Nuclear Material: A Nuclear Security Success Story Still in Progress
One of the most significant achievements in reducing the risk of nuclear terrorism over the past two decades is something that rarely makes headlines.
Risky Business
Welcome to the blog
Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Get To Know NTI: Amanda Krieger
Humidity, Hard Truths, and the Future of Global Health Security
A Simple Step to Close a Dangerous Biosecurity Gap
Three Strikes: Why Giving Up on the NPT Is Not an Option
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
How to prevent AI-enabled bioterrorism
AI biodesign tools offer many beneficial uses, from engineered crops to vaccine development, but tools that can engineer biological agents could also be misused to cause harm.
Exploring AI-Biosecurity Governance in the Global South
Gaps in healthcare infrastructure and biosecurity capabilities among Global South countries make these regions particularly vulnerable to biological threats, both natural and man-made.
NTI | bio Advances International Dialogue on AI Biosecurity Through Expert Working Groups
NTI | bio convened two technical working groups this fall to address critical challenges at the intersection of AI and the life sciences, bringing together more than 50 international experts from major AI companies, academic institutions, and biosecurity organizations.
BWC at 50: Taking Bold Steps to Secure the Future
2025 marks 50 years of the Biological Weapons Convention (BWC). It faces significant challenges and there is an urgent need to modernize the BWC, ensuring it keeps pace with scientific developments and reinforces global biosecurity.
Russian Biological Facility Build-up Underscores Need for Enhanced Transparency
The Washington Post’s chilling report on major activity at a former bioweapons research site where the Soviets once weaponized biological agents — including ones that cause Smallpox, Ebola, and other hemorrhagic fevers — is another dangerous development potentially related to Russia’s war on Ukraine.
NTI | bio Offers Solutions to Strengthen Biosecurity and Reduce Biological Threats
Given rising H5N1 bird flu cases in cows and new cases in humans, enhancing global pandemic detection, prevention, and response is crucial. The Global Health Security Conference (GHSC) earlier this summer provided an excellent opportunity for health and security leaders to discuss solutions to address biological threats.
“The World is Watching”: Dr. Luciana Borio on the U.S. Response to Bird Flu
Biodefense and infectious disease specialist and NTI board member Luciana Borio, M.D. on the challenges, opportunities, and priorities for marshalling an effective response to H5N1 bird flu.
Diverse Voices in Global Biosecurity: Dr. Andrew Hebbeler on the importance of leading with humility
NTI is committed to highlighting and supporting LGBTQ+ voices in national security during Pride Month and beyond. Sarah Stern, NTI’s Global Biological Policy and Programs intern, had the opportunity to speak with Dr. Andrew Hebbeler, the inaugural Director of Biosecurity at the Coalition for Epidemic Preparedness Innovations (CEPI) and former Senior Director of Global Biological Policy and Programs at NTI, about the importance of diversity in biosecurity work and how he views his personal leadership style.
Beyond Borders, Beyond Biases: Building a Biosecure Future with Diverse Voices
NTI | bio Senior Program Officer Dr. Aparupa Sengupta on why efforts to strengthen global biosafety and biosecurity must prioritize diversity and inclusion.
Identifying Outbreak Origins: How the Joint Assessment Mechanism Can Improve Pandemic Response
NTI is working with international partners to develop a new Joint Assessment Mechanism (JAM) within the office of the UN Secretary-General to rapidly identify outbreak origins. Without the ability to quickly determine the origin of an outbreak, researchers are hampered in their ability to rapidly develop vaccines and other medical countermeasures that can slow the pace of the outbreak, ultimately saving countless lives.
Risky Business is edited by:
Scott Nolan Smith
Senior Director, Communications
Mary Olney Fulham
Director, Communications